Trial
NCT05232227
Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, San Francisco
Collaborators
Pan American Health Organization
Condition
Malaria, Vivax
Intervention
Primaquine double dose over 14 days
Why stopped
Trial terminated by funder
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-11